ArticleMedicine2025
Causal relationship between branched-chain amino acids and their metabolites and frailty: A two-sample Mendelian randomization study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increasing evidence suggests that branched-chain amino acids (BCAAs) are associated with frailty. However, whether there is a causal relationship between them remains to be seen. In addition, the metabolism of amino acids in the body is complex, and many previous studies have neglected the effects of their metabolites. The aim of this study was to investigate the relationship between BCAAs and their metabolites and indicators of frailty through Mendelian randomization (MR) methods, so as to determine the causal relationship between the 2, and to provide potential information for preventive and therapeutic strategies for frailty. A MR study was conducted using public genome-wide association studies (GWAS) data, applying inverse variance weighted as the primary method and complementary methods such as MR-Egger, weighted median, and mode. Cochran Q and MR-Egger were used to assess heterogeneity and pleiotropy. MR-PRESSO was utilized to detect and correct horizontal pleiotropy effects. The inverse variance weighted analysis suggested significant causal associations between acetoacetate levels and hand grip strength (left), acetoacetate levels, plasma isobutyrylcarnitine (C4) levels in chronic kidney disease and leucine and hand grip strength (right), leucine, valine, isoleucine and total concentration of BCAAs (leucine + isoleucine + valine) and frailty index, isoleucine, leucine, total concentration of BCAAs (leucine + isoleucine + valine) and valine and usual walking pace, propionylcarnitine levels and isobutyrylcarnitine (c4) levels and weight loss (P < .05), while no causal associations between BCAA and other frailty traits. The sensitivity analysis found the results to be robust. This study provided support for a causal association between BCAAs and their metabolites and frailty. Further exploration was still required to understand the potential mechanism.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.